SynthesisFrontiers in pharmacology2024

Efficacy and safety of PARP inhibitor maintenance therapy for ovarian cancer: a meta-analysis and trial sequential analysis of randomized controlled trials.

Guojuan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.